PhRMA Continues Push For Medicare Part D Redesign In Drug Pricing Legislation

High-cost-medication
PhRMA sees prospects for Medicare Part D redesign in drug pricing legislation
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet